4 ms·
Of course we know how to begin. We're doing it as we speak! Cancer survival rates are constantly getting better. The payback for investment in biotech research
by light_hue_1 3y ago
Of course we know how to begin. We're doing it as we speak!
Cancer survival rates are constantly getting better. The payback for investment in biotech research has been huge and even bigger dividends are on the horizon.
Look at the Hepatitis drugs and weight loss drugs that actually work. These along will address the leading causes of death today.
Coming soon is xenotransplantation. Already we're experimenting with hearts. The outlook is that in 10 years we'll routinely be doing this. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143783/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143783/
> There are ideas for universal treatments for cancer and aging - hundreds of them. Which ones do we dump our billions and billions into investigating?
There really aren't. The basic technology is mostly the same. And we have a system for deciding what to spend money on: scientists write grants, get some funding, show results, and then we repeat at a bigger scale seeing who can deliver the best results. It's not perfect, but it works.
Cancer deaths today are a choice we make as a society to not invest in research. We can't "cure cancer" tomorrow, but even with the tiny resources allocated today we're making significant progress. We could do so much more!
For example, in the 70s 5-year survival across all cancers was 58%. Now it's 85%.
- dralley 3y agoThe point is that it's a problem where "9 women can't make a baby in a month". It's a slow, iterative, grinding advance in many different directions more than something that could be cracked in a decade with sufficient resources.